Clinical Trial Update: A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Pertuzumab in combination with Herceptin (trastuzumab) and chemotherapy in patients with HER2-positive breast cancer; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-20